Enhanced hit-to-lead process using bioanalogous lead evolution and chemogenomics: application in designing selective matrix metalloprotease inhibitors

Author： Papp Ákos   Szommer Tamás   Barna László   Gyimesi Gergely   Ferdinandy Péter   Spadoni Cesare   Darvas Ferenc   Fujita Toshio   Ürge László   Dormán György  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.2, Iss.5, 2007-05, pp. : 707-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preface [Hot topic: Hit-to-Lead: Driving Forces for the Medicinal Chemist (Guest Editor: Benoit Deprez and Rebecca Deprez-Poulain)]

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-02 ,pp. : i-i

Bentham Science Publishers

Access to resources Recommend Favorite

The COREPA approach to lead generation: an application to ACE-inhibitors

By Kamenska V.   Ivanov J.   Mekenyan O.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 9, 1999-09 ,pp. : 687-699

Elsevier

Access to resources Recommend Favorite

Structure Based Lead Optimization Approach in Discovery of Selective DPP4 Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-05 ,pp. : 888-914

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Potential of Matrix Metalloprotease Inhibitors in Cancer Therapy

By Heath E.I.  

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1043-1055

Adis International

Access to resources Recommend Favorite

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain

By Dev Rishabh   Srivastava Punit Kumar   Iyer Jitesh P   Dastidar Sunanda G   Ray Abhijit  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 455-468

Informa Healthcare

Access to resources Recommend Favorite